Accueil・Liste d'Actions・Certara Inc

Certara Inc

Fermé

SecteurSoins de santé

8.07 -1.22

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

7.99

Max

8.18

Chiffres clés
By Trading Economics
Revenu	-2.9M -8.8M
Ventes	3.3M 107M
P/E Moyenne du Secteur	100.714 68.51
BPA	0.09
Marge bénéficiaire	-8.196
Employés	1,515
EBITDA	-16M 16M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+1.73% upside

Dividendes
By Acuity
Prochains Résultats	5 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	474M 1.3B
Ouverture précédente	9.29
Clôture précédente	8.07

Sentiment de l'Actualité

By Acuity

50%

128 / 340 Classement par Healthcare

Certara Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 août 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 août 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 août 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 août 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 août 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 juil. 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 juil. 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 juil. 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28 juil. 2026, 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27 juil. 2026, 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24 juil. 2026, 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23 juil. 2026, 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22 juil. 2026, 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20 juil. 2026, 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Comparaison

Variation de prix

Certara Inc prévision

Objectif de Prix

By TipRanks

1.73% hausse

Prévisions sur 12 Mois

Moyen 8.21 USD 1.73%

Haut 9 USD

Bas 7 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

9 ratings

Achat

Maintien

Vente

Basé sur 9 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

128 / 340Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.